A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk-Reference-Cited by-同舟云学术

A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk

Published:2010-05-07 Issue:6 Volume:49 Page:767-775
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Andersson Ulrika,Schwartzbaum Judith,Wiklund Fredrik,Sjöström Sara,Liu Yanhong,Tsavachidis Spyros,Ahlbom Anders,Auvinen Anssi,Collatz-Laier Helle,Feychting Maria,Johansen Christoffer,Kiuru Anne,Lönn Stefan,Schoemaker Minouk J.,Swerdlow Anthony J.,Henriksson Roger,Bondy Melissa,Melin Beatrice

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2010.480980

Reference35 articles.

1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

2. Genetic epidemiology of glioma

3. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21

4. Association of Genetic Variants at 8q24 with Breast Cancer Risk

5. Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan;Journal of Biomedical Science;2024-02-13

2. Differential expression of the circadian clock network correlates with tumour progression in gliomas;BMC Medical Genomics;2023-07-03

3. Mechanism of action of paclitaxel for treating glioblastoma based on single-cell RNA sequencing data and network pharmacology;Frontiers in Pharmacology;2022-11-21

4. Prediagnostic biomarkers for early detection of glioma—using case–control studies from cohorts as study approach;Neuro-Oncology Advances;2022-11-11

5. Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial;Journal of Neuro-Oncology;2021-11-17